Question 1

What is the catalog number for O-tert-Butyl-L-trans-4-hydroxyproline tert-butyl ester hydrochloride?

Accepted Answer

The catalog number for O-tert-Butyl-L-trans-4-hydroxyproline tert-butyl ester hydrochloride is sc-472086.

Question 2

What sizes are available for O-tert-Butyl-L-trans-4-hydroxyproline tert-butyl ester hydrochloride?

Accepted Answer

O-tert-Butyl-L-trans-4-hydroxyproline tert-butyl ester hydrochloride is available in the following size(s): 1 g.

Question 3

Is O-tert-Butyl-L-trans-4-hydroxyproline tert-butyl ester hydrochloride in stock?

Accepted Answer

O-tert-Butyl-L-trans-4-hydroxyproline tert-butyl ester hydrochloride is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

How long will it take to receive this product if it’s custom made?

Accepted Answer

Lead times depend on the product type: custom polyclonal antibodies typically take 12-14 weeks, monoclonal antibodies 15-17 weeks, made-to-order recombinant proteins 4-8 weeks, and made-to-order recombinant antibodies 6-8 weeks. These are estimates and may shift due to production delays.

Question 5

What is the recommended dilution for this antibody?

Accepted Answer

A recommended dilution range for each validated application is provided on the datasheet, but optimal dilution should be titrated for your specific experimental system, sample type, and detection method.

Question 6

What is the recommended storage temperature after reconstitution?

Accepted Answer

Post-reconstitution storage guidance is listed on the datasheet, typically requiring aliquoting and storage at -20°C or -80°C to preserve activity.

O-tert-Butyl-L-trans-4-hydroxyproline tert-butyl ester hydrochloride

Product Specifications

CAS Number

Frequently Asked Questions

Explore Other Products

CD45 / LCA (2B11 + PD7/26), CF770 conjugate, 0.1mg/mL

CD5 (Cris-1), CF488A conjugate, 0.1mg/mL

CD86 (BU63), CF568 conjugate, 0.1mg/mL

TNF alpha (J2D10), CF647 conjugate, 0.1mg/mL

Complement C4d (C4D204), CF488A conjugate, 0.1mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF594 conjugate, 0.1mg/mL